Tariffs on Indian drugs will be a bitter pill for Americans

Archana Shukla and Nikhil Inamdar

BBC News, Mumbai

Getty Images The image shows Proxyvon tablets arranged for a photograph in Mumbai, India, against a pink background. Getty Images

Millions of Americans could see the cost of medicines shoot up if Trump imposes tariffs on Indian drugs

With Donald Trump’s tit-for-tat tariffs on India looming next month, millions of Americans may have to brace for steeper medical bills.

Last week, Indian Commerce Minister Piyush Goyal made an unscheduled trip to the US for discussions with officials, hoping to strike a trade deal.

It followed Trump’s announcement that he would impose tariffs – which are government taxes on foreign imports – on India by 2 April, in retaliation to India’s tariffs on American goods.

Goyal wants to stave off tax increases on India’s critical export industries like medicinal drugs.

Nearly half of all medicines taken in the US come from India alone. Generic drugs – which are cheaper versions of brand-name medications – imported from countries like India make up nine out of 10 prescriptions in the US.

This saves Washington billions in healthcare costs. In 2022 alone, the savings from Indian generics amounted to a staggering $219bn (£169bn), according to a study by consulting firm IQVIA.

Without a trade deal, Trump’s tariffs could make some Indian generics unviable, forcing companies to exit part of the market and exacerbating existing drug shortages, experts say.

Tariffs could “worsen the demand-supply imbalances” and the uninsured and poor will be left counting the costs, says Dr Melissa Barber, a drug costing expert from Yale University.

The effects could be felt across people suffering from a range of health conditions.

Over 60% of prescriptions for hypertension and mental health ailments in the US were filled with Indian-made drugs, according to the IQVIA study funded by the Indian Pharmaceutical Alliance (IPA).

Sertraline, the most prescribed antidepressant in the US, is a prominent example of how dependent Americans are on Indian supplies for essential drugs.

Many of them cost half as much as for those from non-Indian companies.

“We are worried about this,” says Peter Maybarduk, a lawyer at Public Citizens, a consumer advocacy group fighting for access to medicines. One in four American patients already fail to take medicines due to their costs, he adds.

Trump is already reportedly facing pressure from US hospitals and generic drugmakers because of his tariffs on Chinese imports.

The raw materials for 87% of the drugs sold in the US are located outside the country and primarily concentrated in China which fulfils around 40% of global supply.

With tariffs on Chinese imports rising 20% since Trump took office, the cost of raw materials for drugs have already gone up.

Getty Images The image shows employees working inside a laboratory at a Laurus Labs Ltd. pharmaceutical plant in Visakhapatnam, Andhra Pradesh, India, wearing white jackets and masks.Getty Images

About 60% of prescriptions for hypertension and mental health ailments in the US are filled with Indian-made drugs

Trump wants companies to shift manufacturing to the US to avoid his tariffs.

Big pharma giants like Pfizer and Eli Lily, that sell brand name and patented drugs, have said they are committing to move some manufacturing there.

But the economics for low-value drugs do not add up.

Dilip Shanghvi, chairman of India’s largest drugmaker Sun Pharma, told an industry gathering last week that his company sells pills for between $1 and $5 per bottle in the US and tariffs “do not justify relocating our manufacturing to the US”.

“Manufacturing in India is at least three to four times cheaper than in the US,” says Sudarshan Jain of the IPA.

Any quick relocation will be next to impossible. Building a new manufacturing facility can cost up to $2bn and take five to 10 years before it is operational, according to lobby group PhRMA.

Getty Images The image shows Piyush Goyal, India's trade minister speaking at an event in New Delhi, India in 2019. Getty Images

With Donald Trump’s tariffs looming, Indian Commerce Minister Piyush Goyal made an unscheduled trip to the US last week

For local pharma players in India, the tariff blow could be brutal too.

The pharmaceutical sector is India’s largest industrial export according to GTRI, a trade research agency.

India exports some $12.7bn worth of drugs to the US annually, paying virtually no tax. US drugs coming into India, however, pay 10.91% in duties.

This leaves a “trade differential” of 10.9%. Any reciprocal tariffs by the US would increase the costs for both generic medicines and specialty drugs, according to GTRI.

It flags up pharmaceuticals as one of the sectors that is most vulnerable to price increases in the US market.

Indian firms which largely sell generic drugs already work on thin margins and won’t be able to afford a steep tax outgo.

They sell at much lower prices compared to competing peers, and have steadily gained dominance across cardiovascular, mental health, dermatology and women’s health drugs in the world’s largest pharma market.

“We can offset single-digit tariff hikes with cost cuts, but anything higher will have to be passed down to consumers,” the finance head of a top Indian drugmaker who didn’t want to be identified, told the BBC.

North America is their biggest revenue source, contributing a third of the earnings and profitability of most companies.

“It is the fastest growing market and most crucial. Even if we increase exposure to other markets, it will not adjust for any loss in the US market,” the finance head said.

Umang Vohra, CEO of India’s third-largest drug firm Cipla, said at a public gathering recently that tariffs should not ultimately dictate what businesses do, “because there is a risk that four years later, those tariffs may go away”.

But four years is a long time, and could make or break the fortunes of several companies.

Getty Images U.S. President Donald Trump is pictured signing executive orders in the Oval Office of the White House on March 06, 2025. Getty Images

India has agreed to cut tariffs “way down”, Donald Trump said recently

To avoid any of this, “India should just drop its tariffs on pharma goods”, Ajay Bagga, a veteran market expert told the BBC. “US drug exports into India are barely half a billion dollars, so the impact will be negligible.”

The IPA, which consists of India’s largest drug makers, has also recommended zero duty on US drug exports so that India isn’t negatively impacted by reciprocal levies.

Indian Prime Minister Narendra Modi’s government recently added 36 life-saving drugs to the list of medicines fully exempted from a basic customs duty in the budget, and President Trump dropped a hint last week that India could be yielding to his pressure.

India has agreed to cut tariffs “way down”, he said, because “somebody is finally exposing them for what they have done”.

Delhi has not responded yet, but pharma players in both countries are nervously waiting to see the specifics of a trade deal that could have a bearing on lives and livelihoods.

“In the short term, there may be some pain through new tariffs, but I think they’ll make significant progress by the fall of this year for a first tranche [trade] agreement,” Mark Linscott, former assistant US trade representative, told the BBC, adding that neither country could afford a breakdown in pharma supply chains.

Follow BBC News India on Instagram, YouTube, X and Facebook.

Visited 1 times, 1 visit(s) today

Related Article

China’s Campus Propaganda Pipeline – China Media Project

In a move that highlights China’s expanding use of institutions down to the local level to supercharge the state’s global influence efforts, the School of Foreign Languages at Xi’an Jiaotong University, a leading public university in the central Chinese city, has formed a partnership with a center run by the province’s propaganda office.  On March

I bought my Tesla years before Elon Musk went MAGA. Don’t judge me

To the editor: When did the brand of car I drive become a political statement? I’ve driven an electric car for 12 years not to make a statement, but to do my small part to fight climate change. But lately, my 2013 Tesla Model S with 112,000 miles has become a symbol of my “support”

Yunus to visit Beijing, meet Xi on March 28

DHAKA: Chief adviser Muhammad Yunus will meet Chinese President Xi Jinping in Beijing on March 28, underscoring the continued efforts of both nations to deepen their strategic cooperation. The meeting will also mark the 50th anniversary of Bangladesh-China diplomatic relations, and there is apossibility of signing several bilateral agreements, said a diplomatic source. At the

Schumer votes to keep government open

Senate Minority Leader Chuck Schumer, D-N.Y., says he will vote to keep the government open, warning that a shutdown has worse consequences for Americans and would only empower President Trump and Elon Musk further. “I believe it is my job to make the best choice for the country to minimize the harms to the American

Jeff Bezos Is Genius Who Helped Benefit Himself And The World With Amazon, VC Says: ‘The Beneficiary Is The Consumer’ – Amazon.com (NASDAQ:AMZN)

Venture capitalist Tim Draper has invested in companies such as Hotmail, Skype, Tesla and SpaceX over the years. While he’s never invested in Amazon.com Inc AMZN, he couldn’t help but praise founder Jeff Bezos for changing the world. Capitalism for Good: Draper is best known for his focus on Bitcoin these days. The venture capitalist

Compass reportedly near a deal to acquire HomeServices

Illustration by Real Estate News/Shutterstock The brokerage giant “is in advanced talks” to buy HomeServices of America, the real estate arm of Warren Buffet’s empire, the Wall Street Journal reports. Compass’ appetite for brokerage competitors continues as the company appears to be pursuing another large player in the residential real estate space.  According to the

Compass In Talks To Acquire BHHS

Compass could be continuing its period of expansion with a massive growth spurt in the form of a deal to buy Berkshire Hathaway HomeServices.  The Wall Street Journal first reported the residential giant was in talks for the country’s fourth-largest brokerage, according to RealTrends.   Terms of the deal have not yet been reported.  The move

Trump asks Supreme Court to allow him to end birthright citizenship

CNN  —  President Donald Trump’s administration asked the Supreme Court in a series of emergency appeals Thursday to allow him to move forward with plans to end birthright citizenship, elevating a fringe legal theory that several lower courts have resoundingly rejected. In a series of emergency appeals, the Trump administration argued that lower courts had

Can the US pry Russia away from China?

Western politicians have repeatedly called on China to limit or cease tacit support for Russia’s bloody war against Ukraine. In response, China’s leadership insists it is committed to peace and respect for the territorial integrity of other nations. But unlike most United Nations member states, China has never condemned Russia’s full-scale invasion of Ukraine, and

Trump sued by 20 states to halt ‘dismantling’ of Education Department

A security guard walks past the U.S. Department of Education headquarters in Washington, D.C., March 12, 2025. Nathan Howard | Reuters A group of Democratic state attorneys general filed a lawsuit against the Trump administration Thursday over its moves to dismantle the U.S. Department of Education and its termination of nearly half the agency’s staff.

Putin says Russia backs Ukraine ceasefire plan but there are nuances

Russian President Vladimir Putin speaks during a bilateral meeting at the Grand Kremin Palace, March 13, 2025, in Moscow, Russia. President of Belarus Lukashenko is having first foreign trip after re-election. Contributor | Getty Images News | Getty Images Russian President Vladimir Putin on Thursday said Russia agrees in principle with the U.S.-led ceasefire plan

Russia Says It Has Retaken Key Kursk Town From Ukraine

Russia’s Defense Ministry said Thursday that the military had regained full control of the town of Sudzha, the main population center in the part of the Kursk region of Russia that Ukrainian troops had captured last summer. Ukrainian officials have not confirmed a retreat from the town, where the previous night Kyiv’s military had reported

One of Wall Street’s big bulls cuts S&P 500 target, blaming Trump’s tariffs

Widely-followed strategist Ed Yardeni, one of the biggest bulls on Wall Street, lowered his market forecast, saying President Donald Trump’s tariffs raise the risk of stagflation. “It has dawned on Wall Street (and us!) that President Trump’s tariffs aren’t negotiating chips to help the U.S. lower tariffs around the world, promoting free trade,” Yardeni said

Elon Musk’s mistakes

Wake up. We’re slowly slip-sliding into a Russian-orchestrated coup. This goes way beyond the jokey rumors that Russian dictator Vladimir Putin is blackmailing Donald Trump with a secret, compromising ‘pee tape.’ Consider how the U.S. voted in the United Nations with Russia, China and Iran against American supposed ally, Ukraine. Now there’s the shocking Oval

Russia’s Putin tells Kursk troops to “defeat” Ukraine as Witkoff flies in

Putin is expected to give a press conference with Belarusian President Alexander Lukashenko, a key ally, later Thursday. Rubio, meanwhile, may discuss the war when he meets with the top diplomats at the Group of Seven, or G-7, summit in Quebec, Canada on Thursday. That might be an awkward appointment for the secretary of state

Is China Ready for Global Leadership?

Predicting China’s stance on any major global issue starts with a simple question: What is the United States’ position? More often than not, China’s approach will be shaped in reaction to US interests. For decades, China has worked to erode US influence in the international system—and thanks to US President Donald Trump, it is closer

US officials travel to Moscow as Putin visits troops in Kursk

US President Donald Trump said negotiators were on their way to Russia to present a ceasefire proposal backed by Ukraine. ADVERTISEMENT US President Donald Trump claimed on Wednesday that Washington’s negotiators were on their way “right now” for talks on a proposed ceasefire with Ukraine, after Kyiv agreed to a 30-day truce. Trump declined to

JP Morgan Chase CEO Jamie Dimon has this Thanks and All the Best message for Elon Musk

Elon Musk has reposted a recent video shared by entrepreneur Mario Nawfal, in which JP Morgan Chase CEO Jamie Dimon praises Musk, calling him “our Einstein.” The video, now making waves on social media, captures Dimon highlighting Musk’s achievements across Tesla, SpaceX, and Neuralink. “You’ve got to look at Elon, at SpaceX, Tesla, Neuralink –

0
Would love your thoughts, please comment.x
()
x